Impairment of mitochondrial quality control exacerbates diabetes-related atrial fibrillation by cGAS-STING signaling pathway and cardiomyocyte-macrophage crosstalk

Dec 8, 2025Theranostics

Poor mitochondrial quality control may worsen diabetes-related irregular heartbeats through immune signaling and heart cell communication

AI simplified

Longevity & Aging on OpenScience ↗PubMed ↗DOI ↗

Abstract

A high-fat diet combined with streptozotocin induced significant atrial fibrillation susceptibility in diabetic mice.

Diabetes is associated with increased atrial fibrillation inducibility, oxidative stress, and mitochondrial abnormalities.
The cGAS-STING signaling pathway is activated by mitochondrial DNA, contributing to inflammatory responses in the atria.
Dysregulation of mitochondrial quality control mechanisms, including impaired mitophagy and reduced mitochondrial biogenesis, was observed in diabetic conditions.
Macrophages engulf cardiomyocyte-derived mitochondrial DNA, leading to their polarization towards an inflammatory state.
Pharmacological treatment with mitochondrial antioxidants or STING knockdown reduced inflammation and atrial remodeling in diabetic mice.

AI simplified

Type 2 diabetes mellitus (T2DM) significantly elevates the likelihood of atrial fibrillation (AF); However, the precise mechanisms remain incompletely elucidated. Mitochondrial dysfunction is a hallmark of diabetic cardiomyopathy, and recent evidence suggests that activation of the cGAS-STING signaling pathway may contribute to metabolic inflammation in the atria. This study aims to investigate the role of mitochondrial DNA (mtDNA)-mediated cGAS-STING activation in promoting diabetes-associated atrial fibrillation (AF) through cardiomyocyte-macrophage crosstalk.Using a high-fat diet combined with streptozotocin through intraperitoneal injection, we induced a diabetic mouse model. We observed increased AF inducibility, oxidative stress, and mitochondrial ultrastructural abnormalities, along with elevated expression of STING pathway components and pro-inflammatory cytokines in atrial tissue. RNA sequencing and histological analyses confirmed dysregulation of mitochondrial quality control (MQC), including impaired mitophagy, imbalance in fusion and fission, and reduced mitochondrial biogenesis., HL-1 atrial cardiomyocytes exposed to high glucose and palmitic acid showed excessive production of mtROS and cytosolic release of mitochondrial DNA (mtDNA), which in turn triggered cGAS-STING activation. A transwell co-culture system revealed that cardiomyocyte-derived mtDNA was engulfed by RAW 264.7 macrophages, promoting M1 polarization of macrophages and further amplifying inflammatory signaling. Importantly, pharmacological intervention with the mitochondrial antioxidant mito-TEMPO or cardiomyocyte-specific STING knockdown suppressed inflammatory responses, reversed atrial remodeling, and reduced AF susceptibility. Notably, STING overexpression sustained inflammatory pathways independently of suppressing oxidative stress, highlighting cGAS-STING signaling as a downstream effector of mitochondrial damage.Impairment of mitochondrial quality control promotes atrial inflammation and remodeling in diabetes through mtDNA-induced cGAS-STING activation and cardiomyocyte-macrophage communication. Targeting this pathway may offer a novel strategy for AF management in metabolically compromised hearts. Aims: Methods and results: Conclusion: In vitro

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

View full text ↗

Impairment of mitochondrial quality control exacerbates diabetes-related atrial fibrillation by cGAS-STING signaling pathway and cardiomyocyte-macrophage crosstalk

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief